Abstract
Paclitaxil is a non-water soluble anti-cancer drug with problems of solvent related toxicities due to use of ethanol and polyethylated castor-oil for administration. Several formulations have been prepared to overcome the solubility problem and the present work describes one of such possibility of the preparation of water-soluble paclitaxil nanoparticles by Emulsion-solvent evaporation technique. The paclitaxil nanoparticles were prepared by nanoemulsification using human serum albumin as polymer. The prepared nanoparticles were evaluated by stability studies, encapsulating efficiency, in-vitro toxicity studies. It aims to verify the in vivo capacity of the formed nanoparticles to reduce the toxicity, which would have been caused by the conventional Cremophor EL. The prepared nanoparticles were soluble in 0.9%NaCl, showed better encapsulating efficiency and the reconstituted solution was stable for more than 24 hrs. In-vivo abnormal toxicity studies were carried out on albino mice and guinea pig and showed that the paclitaxilnanoparticles formed had no toxicity as compared to Cremophor EL.
Keywords: Nanoparticles, albumin, reduced toxicity, paclitaxil, homogenization, bio-degradable, stability, lyophilization
Current Bioactive Compounds
Title: Preparation of Water-Soluble Albumin Loaded Paclitaxil Nanoparticles Using Emulsion-Solvent Evaporation Technique
Volume: 4 Issue: 1
Author(s): A. Anil Yadav and Shanthi Vadali
Affiliation:
Keywords: Nanoparticles, albumin, reduced toxicity, paclitaxil, homogenization, bio-degradable, stability, lyophilization
Abstract: Paclitaxil is a non-water soluble anti-cancer drug with problems of solvent related toxicities due to use of ethanol and polyethylated castor-oil for administration. Several formulations have been prepared to overcome the solubility problem and the present work describes one of such possibility of the preparation of water-soluble paclitaxil nanoparticles by Emulsion-solvent evaporation technique. The paclitaxil nanoparticles were prepared by nanoemulsification using human serum albumin as polymer. The prepared nanoparticles were evaluated by stability studies, encapsulating efficiency, in-vitro toxicity studies. It aims to verify the in vivo capacity of the formed nanoparticles to reduce the toxicity, which would have been caused by the conventional Cremophor EL. The prepared nanoparticles were soluble in 0.9%NaCl, showed better encapsulating efficiency and the reconstituted solution was stable for more than 24 hrs. In-vivo abnormal toxicity studies were carried out on albino mice and guinea pig and showed that the paclitaxilnanoparticles formed had no toxicity as compared to Cremophor EL.
Export Options
About this article
Cite this article as:
Yadav Anil A. and Vadali Shanthi, Preparation of Water-Soluble Albumin Loaded Paclitaxil Nanoparticles Using Emulsion-Solvent Evaporation Technique, Current Bioactive Compounds 2008; 4 (1) . https://dx.doi.org/10.2174/157340708784533410
DOI https://dx.doi.org/10.2174/157340708784533410 |
Print ISSN 1573-4072 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6646 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
RNA Sensors as a Mechanism of Innate Immune Evasion among SARSCoV2, HIV and Nipah Viruses
Current Protein & Peptide Science Mechanism of Cancer Drug Resistance and the Involvement of Noncoding RNAs
Current Medicinal Chemistry T Lymphocytes as Targets of Gene Transfer with Moloney-Type Retroviral Vectors
Current Gene Therapy Irreversible Inhibition of Serine Proteases – Design and In Vivo Activity of Diaryl α-Aminophosphonate Derivatives
Current Medicinal Chemistry The Chemokine System as a Therapeutic Target in Autoimmune Thyroid Diseases: A Focus on the Interferon-γ Inducible Chemokines and their Receptor
Current Pharmaceutical Design Current and Emerging Systemic Therapy in Gastro-Esophageal Cancer “The Old and New Therapy for Metastatic Disease, The Role of Adjuvant and Neoadjuvant Therapy for Localized Disease”
Current Clinical Pharmacology Arsenic Trioxide Exerts Anti-lung Cancer Activity by Inhibiting Angiogenesis
Current Cancer Drug Targets Cancer Vaccines: Emphasis on Pediatric Cancers
Current Pharmaceutical Design EXTraordinary Bones: Functional and Genetic Analysis of the EXT Gene Family
Current Genomics PEGylated Liposomal Vancomycin: A Glimmer of Hope for Improving Treatment Outcomes in MRSA Pneumonia
Recent Patents on Anti-Infective Drug Discovery Analysis of the Potential for HIV-1 Vpr as an Anti-Cancer Agent
Current HIV Research New Therapeutic Property of Dimebon as a Neuroprotective Agent
Current Medicinal Chemistry Current Management of Fetal and Neonatal Renal Tumors
Current Pediatric Reviews PEGylation: An Overview and Recent Advances Reported in the Patent Literature
Recent Patents on Chemical Engineering Prodrugs in Photodynamic Anticancer Therapy
Current Pharmaceutical Design Drug-Loaded Nanocarriers in Tumor Targeted Drug Delivery
Current Biotechnology Targeting BMP9-Promoted Human Osteosarcoma Growth by Inactivation of Notch Signaling
Current Cancer Drug Targets Clinical Pharmacogenetics in Oncology: the Paradigm of Molecular Targeted Therapies
Current Pharmaceutical Design Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed
Current Drug Targets The Development of Oncolytic Adenovirus Therapy in the Past and Future - For the Case of Pancreatic Cancer
Current Cancer Drug Targets